The Procter & Gamble Company (NYSE:PG - Get Free Report)'s share price traded up 0.1% on Tuesday . The company traded as high as $179.01 and last traded at $177.52. 1,645,392 shares changed hands during mid-day trading, a decline of 76% from the average session volume of 6,721,701 shares. The stock had previously closed at $177.39.
Analyst Ratings Changes
PG has been the topic of a number of research reports. StockNews.com lowered Procter & Gamble from a "buy" rating to a "hold" rating in a report on Thursday, August 1st. Morgan Stanley upped their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a research note on Monday, October 21st. DA Davidson upgraded Procter & Gamble from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $160.00 to $209.00 in a report on Monday. Dbs Bank downgraded Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Thursday, August 1st. Finally, Piper Sandler began coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a "neutral" rating and a $174.00 price target on the stock. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Procter & Gamble currently has a consensus rating of "Moderate Buy" and an average price target of $180.45.
Check Out Our Latest Report on PG
Procter & Gamble Trading Up 0.9 %
The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The stock has a market cap of $421.41 billion, a price-to-earnings ratio of 30.61, a P/E/G ratio of 3.81 and a beta of 0.42. The business's 50 day moving average is $170.04 and its 200 day moving average is $168.74.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period in the prior year, the firm posted $1.83 earnings per share. The firm's revenue was down .6% on a year-over-year basis. As a group, equities analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.25%. Procter & Gamble's payout ratio is 69.31%.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total value of $6,289,463.60. Following the sale, the chief executive officer now owns 263,537 shares of the company's stock, valued at approximately $44,508,763.93. The trade was a 12.38 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Susan Street Whaley sold 634 shares of the firm's stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares of the company's stock, valued at $3,319,882.65. This represents a 3.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 72,473 shares of company stock worth $12,313,697 in the last quarter. Company insiders own 0.18% of the company's stock.
Institutional Trading of Procter & Gamble
A number of institutional investors have recently bought and sold shares of PG. Asset Advisors Investment Management LLC increased its stake in shares of Procter & Gamble by 0.3% during the 3rd quarter. Asset Advisors Investment Management LLC now owns 50,887 shares of the company's stock worth $8,814,000 after purchasing an additional 174 shares in the last quarter. Synovus Financial Corp increased its position in Procter & Gamble by 3.4% during the third quarter. Synovus Financial Corp now owns 185,134 shares of the company's stock worth $32,065,000 after buying an additional 6,077 shares in the last quarter. Destination Wealth Management raised its holdings in shares of Procter & Gamble by 0.7% in the third quarter. Destination Wealth Management now owns 55,058 shares of the company's stock worth $9,536,000 after acquiring an additional 392 shares during the last quarter. Wilmington Savings Fund Society FSB lifted its position in shares of Procter & Gamble by 505.6% in the third quarter. Wilmington Savings Fund Society FSB now owns 645,475 shares of the company's stock valued at $111,796,000 after acquiring an additional 538,889 shares in the last quarter. Finally, Arvest Bank Trust Division acquired a new stake in shares of Procter & Gamble during the third quarter valued at $13,103,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
About Procter & Gamble
(
Get Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.